F. Rosen

Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience

Bruce Brockstein, Daniel J. Haraf, Alfred Rademaker et al. · Annals of Oncology · 2004 · 368 citations · Full text

Advanced Head, Neck Cancer, Health Sciences +8

Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels

Joseph K. Salama, K. M. Stenson, Emily O. Kistner et al. · Annals of Oncology · 2008 · 65 citations · Full text

Advanced Head, Neuro-oncology, Radiotherapy Dose Levels +10

Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303)

H. J. Wanebo, J. Lee, Barbara Burtness et al. · Annals of Oncology · 2014 · 56 citations · Full text

Medicine, Pathology, Induction Cetuximab +8

Phase II induction cetuximab (C225), paclitaxel (P), and carboplatin (C) followed by chemoradiation with C225, P, C, and RT 68-72Gy for stage III/IV head and neck squamous cancer: Primary site organ preservation and disease control at 2 years (ECOG, E2303).

H. J. Wanebo, Musie Ghebremichael, Barbara Burtness et al. · Journal of Clinical Oncology · 2010 · 16 citations

Surgical Oncology, Induction C225, Pathology +20

Anaplastic carcinoma of the thyroid with abnormal circulating iodoprotein: a case simulating subacute thyroiditis.

F. Rosen, VAS V. ROW, Robert J. Volpe et al. · PubMed · 1966 · 14 citations · Full text

Thyroid Disease, Subacute Thyroiditis, Thyroid Hormone +1